Account-creators
1,040
edits
Difference between revisions of "Pit1"
Jump to navigation
Jump to search
+ ref
Jensflorian (talk | contribs) (→Positive: +ref) |
Jensflorian (talk | contribs) (+ ref) |
||
| Line 16: | Line 16: | ||
}} | }} | ||
'''POU domain, class 1, transcription factor 1''' (growth hormone factor 1), also known as POU1F1, abbreviated '''Pit1''', is a | '''POU domain, class 1, transcription factor 1''' (growth hormone factor 1), also known as POU1F1, abbreviated '''Pit1''', is a [[immunostain]] used endocrinology. | ||
==General== | ==General== | ||
| Line 28: | Line 28: | ||
* Lactotroph adenoma. | * Lactotroph adenoma. | ||
* Thyreotropha adenoma. | * Thyreotropha adenoma. | ||
* Mammary gland.<ref>{{Cite journal | last1 = Sendon-Lago | first1 = J. | last2 = Seoane | first2 = S. | last3 = Eiro | first3 = N. | last4 = Bermudez | first4 = MA. | last5 = Macia | first5 = M. | last6 = Garcia-Caballero | first6 = T. | last7 = Vizoso | first7 = FJ. | last8 = Perez-Fernandez | first8 = R. | title = Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13. | journal = Breast Cancer Res | volume = 16 | issue = 6 | pages = 505 | month = Dec | year = 2014 | doi = 10.1186/s13058-014-0505-8 | PMID = 25527274 }}</ref> | |||
| Line 33: | Line 34: | ||
==Negative== | ==Negative== | ||
* Corticotroph adenoma. | |||
* Gonadotroph adenoma. | |||
* Null cell adenoma. | |||
==See also== | ==See also== | ||